Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Core Laboratories Inc. /DE/ Director's Dealing 2023

Aug 2, 2023

32685_dirs_2023-08-02_1d20d69b-b426-41b0-af9e-b6c3f9bf926d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Core Laboratories Inc. /DE/ (CLB)
CIK: 0001958086
Period of Report: 2023-08-01

Reporting Person: Tattoli Mark Damian (SVP, Gen Counsel & Secretary)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-08-01 Common Stock F 100 $27.43 Disposed 5664.621 Direct
2023-08-01 Common Stock M 250 $0.00 Acquired 5764.621 Direct
2023-08-01 Common Stock F 47 $27.43 Disposed 5514.621 Direct
2023-08-01 Common Stock M 120 $0.00 Acquired 5561.621 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-08-01 Restricted Shares $ M 250 Disposed Common Stock (250) Direct
2023-08-01 Restricted Shares $ M 120 Disposed Common Stock (120) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 20 Indirect
Common Stock 1694.842 Indirect

Footnotes

F1: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date.

F2: Mulitple restricted share grants are included in this total.